Table 3.
Chi-Square Analysis Between Creator Types and Issues Related to COVID-19 Vaccination
| Title | Name | Creator Type (%) | Total | χ2 | p | |||
|---|---|---|---|---|---|---|---|---|
| Individuals | Medical Workers | Media | Corporate Companies | |||||
| Issue 1 | None | 68(90.67) | 26(86.67) | 82(89.13) | 5(100.00) | 181(89.60) | 0.971 | 0.808 |
| Yes | 7(9.33) | 4(13.33) | 10(10.87) | 0(0.00) | 21(10.40) | |||
| Total | 75 | 30 | 92 | 5 | 202 | |||
| Issue 2 | None | 63(84.00) | 18(60.00) | 68(73.91) | 4(80.00) | 153(75.74) | 7.047 | 0.07 |
| Yes | 12(16.00) | 12(40.00) | 24(26.09) | 1(20.00) | 49(24.26) | |||
| Total | 75 | 30 | 92 | 5 | 202 | |||
| Issue 3 | None | 38(50.67) | 22(73.33) | 63(68.48) | 4(80.00) | 127(62.87) | 8.06 | 0.045* |
| Yes | 37(49.33) | 8(26.67) | 29(31.52) | 1(20.00) | 75(37.13) | |||
| Total | 75 | 30 | 92 | 5 | 202 | |||
| Issue 4 | None | 60(80.00) | 29(96.67) | 79(85.87) | 5(100.00) | 173(85.64) | 5.75 | 0.124 |
| Yes | 15(20.00) | 1(3.33) | 13(14.13) | 0(0.00) | 29(14.36) | |||
| Total | 75 | 30 | 92 | 5 | 202 | |||
| Issue 5 | None | 42(56.00) | 19(63.33) | 42(45.65) | 3(60.00) | 106(52.48) | 3.623 | 0.305 |
| Yes | 33(44.00) | 11(36.67) | 50(54.35) | 2(40.00) | 96(47.52) | |||
| Total | 75 | 30 | 92 | 5 | 202 | |||
| Issue 6 | None | 52(69.33) | 18(60.00) | 77(83.70) | 5(100.00) | 152(75.25) | 10.323 | 0.016* |
| Yes | 23(30.67) | 12(40.00) | 15(16.30) | 0(0.00) | 50(24.75) | |||
| Total | 75 | 30 | 92 | 5 | 202 | |||
Notes: Issue 1: contraindicated groups for COVID-19 vaccination; Issue 2: suitable groups for COVID-19 vaccination; Issue 3: adverse reactions after COVID-19 vaccination; Issue 4: the Feeling of Vaccination; Issue 5: brands of COVID-19 vaccine; Issue 6: procedures for COVID-19 vaccination. *p<0.05.